Sternal wound complications in patients undergoing orthotopic heart transplantation.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 23 11 2018
revised: 05 02 2019
accepted: 07 02 2019
pubmed: 26 2 2019
medline: 20 7 2019
entrez: 26 2 2019
Statut: ppublish

Résumé

The incidence and management of sternal wound complications in patients undergoing orthotopic heart transplantation (OHT) is not well studied. We report outcomes in heart transplant patients who developed sternal infections requiring reoperations. From 2004 to 2013, 437 patients underwent OHT at a single institution. In a retrospective review, patients who developed sternal infections (Infection group, n = 27) were compared with those without (Control group, n = 410). Sternal infection rate was 6.2% (n = 27). Demographics were similar (Table 1). Infection group had higher rates of COPD 25% vs 13%, P = 0.03, and previous cardiac surgery via median sternotomy 28% vs 15%, P = 0.03. Infection group had a greater incidence of prolonged ventilation, 44% vs 31%, P = 0.2, renal failure 56% vs 24%, P = 0.001, dialysis requirement 30% vs 10%, P = 0.006, permanent stroke 11% vs 2%, P = 0.02, perioperative myocardial infarction 4% vs 0.2%, P = 0.09. The infection group had a longer ICU stay (524  + 410 vs 187  + 355 hours, P = 0.001) and hospitalization (59  + 28 vs 0.29  + 43 days, P = 0.001). In-hospital/30-day mortality was 30% vs 19%, P = 0.2. The mean time for sternal reoperation at 44  + 50 days. Deep wound infection (41%) and sternal dehiscence (22%) were common presentations. Causative organisms were Enterobacter (22%), Klebsiella (15%), and Pseudomonas (15%). Vancomycin (44%), 4th generation cephalosporin (37%), and fluoroquinolones (30%) were the most commonly used antibiotics. Surgical treatment included sternal debridement with pectoralis muscle flap (52%), primary closure (18%), and omental flap (11%). Sternal wound infections impart a significant burden on patients with OHT. Causative organisms are predominantly virulent gram-negative bacteria. Therefore, a high index of suspicion must be maintained for early detection and treatment.

Identifiants

pubmed: 30803021
doi: 10.1111/jocs.14003
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

186-189

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Tyler J Wallen (TJ)

The University of Pennsylvania Health System, Philadelphia, Pennsylvania.
The University of Florida Health System, Gainesville, Florida.

Andreas Habertheuer (A)

The University of Pennsylvania Health System, Philadelphia, Pennsylvania.

Jean P Gottret (JP)

The University of Pennsylvania Health System, Philadelphia, Pennsylvania.

Matthew Kramer (M)

The University of Pennsylvania Health System, Philadelphia, Pennsylvania.

Zara Abbas (Z)

The University of Pennsylvania Health System, Philadelphia, Pennsylvania.

Mary Siki (M)

The University of Pennsylvania Health System, Philadelphia, Pennsylvania.

Reilly Hobbs (R)

The University of Pennsylvania Health System, Philadelphia, Pennsylvania.

Charlie Vasquez (C)

The University of Pennsylvania Health System, Philadelphia, Pennsylvania.

Maria Molina (M)

The University of Pennsylvania Health System, Philadelphia, Pennsylvania.

Suhail Kanchwala (S)

The University of Pennsylvania Health System, Philadelphia, Pennsylvania.

David Low (D)

The University of Pennsylvania Health System, Philadelphia, Pennsylvania.

Michael Acker (M)

The University of Pennsylvania Health System, Philadelphia, Pennsylvania.

Prashanth Vallabhajosyula (P)

The University of Pennsylvania Health System, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH